{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:06:31Z","timestamp":1777363591012,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.adro.2021.100773","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T04:29:14Z","timestamp":1628742554000},"page":"100773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Toxicity and Efficacy After Adjuvant Vaginal Brachytherapy Using 30 Gy in 6 Fractions for Stages I and II Endometrial Cancer"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-2747","authenticated-orcid":false,"given":"Jessica D.","family":"Arden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Dokter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muayad F.","family":"Almahariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Marvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirisha R.","family":"Nandalur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid","family":"Al-Wahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Gadzinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha Saada","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2021.100773_bib0001","series-title":"SEER cancer statistics review, 1975-2016","author":"Howlader","year":"2019"},{"key":"10.1016\/j.adro.2021.100773_bib0002","article-title":"Uterine neoplasms, version 1.2020","author":"Abu-Rustum","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.adro.2021.100773_bib0003","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A gynecologic oncology group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.adro.2021.100773_bib0004","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2021.100773_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American brachytherapy society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2021.100773_bib0006","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2019.02.008","article-title":"Compendium of fractionation choices for gynecologic HDR brachytherapy-An American Brachytherapy Society Task Group report","volume":"18","author":"Albuquerque","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2021.100773_bib0007","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2021.100773_bib0008","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5114\/jcb.2018.79713","article-title":"Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results","volume":"10","author":"Delishaj","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.adro.2021.100773_bib0009","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ygyno.2005.02.021","article-title":"Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer","volume":"97","author":"Jolly","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.adro.2021.100773_bib0010","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijrobp.2004.12.079","article-title":"Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: A randomized study of two dose-per-fraction levels","volume":"62","author":"Sorbe","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100773_bib0011","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5114\/jcb.2018.74140","article-title":"Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalent to 2 Gy per fraction (alpha\/beta=3 Gy) at 2 cm3 of vagina","volume":"10","author":"Aguilera","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.adro.2021.100773_bib0012","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5114\/jcb.2012.30679","article-title":"Dosimetry and toxicity outcomes in postoperative high-dose-rate intracavitary brachytherapy for endometrial carcinoma","volume":"4","author":"Donnelly","year":"2012","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.adro.2021.100773_bib0013","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5114\/jcb.2015.54952","article-title":"Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer","volume":"7","author":"Sapienza","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.adro.2021.100773_bib0014","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12094-012-0974-0","article-title":"Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity","volume":"15","author":"Valduvieco","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.adro.2021.100773_bib0015","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12094-015-1463-z","article-title":"Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients","volume":"18","author":"Rios","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.adro.2021.100773_bib0016","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2010.10.071","article-title":"Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer","volume":"82","author":"Bahng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100773_bib0017","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s12094-012-0986-9","article-title":"Do comorbidity influences acute toxicity and outcome in elderly patients with endometrial cancer treated by adjuvant radiotherapy plus brachytherapy?","volume":"15","author":"Fiorentino","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.adro.2021.100773_bib0018","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.brachy.2015.03.001","article-title":"Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma","volume":"14","author":"Park","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2021.100773_bib0019","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3802\/jgo.2017.28.e84","article-title":"Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer","volume":"28","author":"Qian","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.adro.2021.100773_bib0020","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10147-017-1147-5","article-title":"Radiation-related toxicities and outcomes in endometrial cancer: Are obese women at a disadvantage?","volume":"22","author":"Smits","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.adro.2021.100773_bib0021","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00404-018-4951-x","article-title":"Quality of life and oncological outcome in endometrial cancer patients after vaginal brachytherapy: Comparison of two dosing schemes","volume":"299","author":"Papathemelis","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.adro.2021.100773_bib0022","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2015.06.016","article-title":"Can we shorten the overall treatment time in postoperative brachytherapy of endometrial carcinoma? Comparison of two brachytherapy schedules","volume":"116","author":"Rovirosa","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2021.100773_bib0023","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.brachy.2017.07.003","article-title":"Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma","volume":"16","author":"Rovirosa","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2021.100773_bib0024","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2018.07.020","article-title":"Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial","volume":"151","author":"Wortman","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.adro.2021.100773_bib0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ajog.2017.01.031","article-title":"Robotic-assisted vs traditional laparoscopic surgery for endometrial cancer: A randomized controlled trial","volume":"216","author":"Madhuri","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.adro.2021.100773_bib0026","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/IGC.0b013e3182a16c93","article-title":"Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer","volume":"23","author":"Weinberg","year":"2013","journal-title":"Int J Gynecol Cancer"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109421001317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109421001317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:41:50Z","timestamp":1762530110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109421001317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2452109421001317"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2021.100773","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity and Efficacy After Adjuvant Vaginal Brachytherapy Using 30 Gy in 6 Fractions for Stages I and II Endometrial Cancer","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2021.100773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100773"}}